Samyang Biopharm USA, Inc. (“SYBUSA”) was founded in 2018 with the headquarters in One Kendall Square, Cambridge, MA.  Playing a vital role as a business hub in the United States, SYBUSA focuses on out-licensing its nucleic acid drug delivery system developed in Samyang Biopharm, a biopharmaceutical business unit in Korea. Over the next few years, SYBUSA will also focus on building partnerships with pharmaceutical companies and co-development joint ventures in the United States. 

Biotechnology

Life Sciences

Pharmaceutical

Samyang Biopharm USA

Samyang Biopharm USA's headquarters in Cambridge, United States

Description

People

Jobs